Publication|Articles|September 13, 2024
- Product Profile: WINREVAIR (sotatercept-csrk, for injection, for subcutaneous use)
Product Profile: WINREVAIR (sotatercept-csrk, for injection, for subcutaneous use)
Advertisement
Learn about a treatment for pulmonary arterial hypertension.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
FDA issues draft guidance on MRD and complete response as primary endpoints for accelerated multiple myeloma drug approvals
3
Cancer survival fell and deaths rose during first two years of COVID-19
4
TrumpRx launches; some experts question its long-term value
5



















